PRAX Stock: Price, Earnings History and SEC Filings
Praxis Precision Medicines, Inc. (PRAX) last traded at $285.93, down 0.93% on the latest session and down 1.8% over the past month. In its most recent reported quarter (Jun 2026) earnings per share were $-2.87 against an analyst estimate of $-3.60, a beat of 20.3%.
$285.93 -0.93%
1 month-1.82%
52-week high$392.70
52-week low$154.45
Volume306,554
ExchangeNasdaqGS
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
PRAX earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | Aug 6, 2026 | $-2.87 | $-3.60 | +20.28% |
| Mar 2026 | May 7, 2026 | $-3.20 | $-3.58 | +10.61% |
| Dec 2025 | Feb 19, 2026 | $-3.50 | $-3.00 | -16.67% |
| Sep 2025 | Nov 5, 2025 | $-3.36 | $-3.45 | +2.61% |
PRAX beat the analyst EPS estimate in 3 of its last 4 reported quarters. Source: Nasdaq.
Latest SEC filings for PRAX
SEC filing data is not available right now. You can search for PRAX on SEC EDGAR.
PRAX news
- Is Investor Day Plans Altering The Investment Case For Praxis Precision Medicines (PRAX)?Oct 28, 2026 · finance.yahoo.com
- Praxis Precision Medicines Announces Third Quarter 2026 Financial Results Date, Investor Day and November Conference ParticipationOct 27, 2026 · finance.yahoo.com
- Epilepsy Market Set to Grow During the Forecast Period (2026-2036) as Novel Antiseizure Therapies Gain Momentum | DelveInsightOct 27, 2026 · finance.yahoo.com
- Praxis Precision Medicines, Inc.Oct 23, 2026 · cnn.com
About Praxis Precision Medicines, Inc.
Praxis Precision Medicines, Inc. (PRAX) is a US-listed public company on Nasdaq.